Dr Souphiyeh Samizadeh explores the science and pharmacological differences of botulinum neurotoxin formulations
ABSTRACT Understanding key anatomical concepts of the face is important in order to be able to treat a patient effectively in any aesthetic treatment. With a robust anatomical knowledge of the occipito-frontalis muscle, the clinician can appreciate how each patient’s anatomy may vary and how the clinician’s choice of injection placement with botulinum toxin A reflects this. Recent detailed anatomical studies of this area provide further clarification regarding static, dynamic and functional anatomy. Through critical analysis of this data, it is possible to tailor treatments on an individual basis.
Training provider The Botulinum Toxin Club has unveiled a new app to help practitioners convert units of botulinum toxin.
Pharmaceutical company Galderma has held numerous intimate round table events across the UK with aesthetic practitioners Dr Yusra Al-Mukhtar, Dr Kuldeep Minocha and Miss Priya Chadha.
Pharmaceutical company Evolus has expanded to offer the neurotoxin Nuceiva in Italy.
A study published in The European Molecular Biology Organization Journal has shed new light on how botulinum toxin is able to infiltrate neurons in the brain.
Miss Priyanka Chadha, Miss Lara Watson and junior doctor Miss Shonnelly Novintan explore the muscle anatomy of the face and its importance in avoiding complications when administering toxin injections
Pharmaceutical company Galderma will be hosting a webinar in partnership with the Aesthetics journal this month.
On March 9, pharmaceutical company Galderma welcomed guests to the highly-anticipated launch of its new liquid neuromodulator Alluzience.
Medical aesthetic company Evolus has announced that its neurotoxin Nuceiva has received approval for sale in Australia.